Dr. Lisa Bailey
Claim this profileContra Costa Regional Medical Center
Expert in Breast Cancer
Expert in Breast cancer
53 reported clinical trials
121 drugs studied
About Lisa Bailey
Education:
- Earned a PhD in Epidemiology and an MPH in Health Education from the University of California at Berkeley.
- Received an MD from Northwestern University.
- Holds a degree in Mathematics from Northwestern University, 1971.
Experience:
- Has been practicing in the East Bay since 1982, with a focus on breast cancer and breast health.
- Completed a General Surgery residency at McGaw Medical Center of Northwestern University Medical School.
- Finished a Surgical Oncology Fellowship at Evanston Hospital in 1981.
- Served as past president and board member of the California Division of the American Cancer Society.
- Chairs the Breast Cancer Taskforce of the American Cancer Society.
- Is a member of the Commission on Cancer of the American College of Surgeons.
Area of expertise
1Breast Cancer
Global LeaderHER2 positive
Stage IV
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 positive
Stage II
Affiliated Hospitals
Clinical Trials Lisa Bailey is currently running
Cabozantinib +/− Atezolizumab
for Advanced Kidney Cancer
This phase II trial compares the effect of atezolizumab in combination with usual treatment with cabozantinib to cabozantinib alone in patients with papillary renal cell carcinoma that has spread from where it first started (primary site) to other places in the body (metastatic). Papillary renal cell carcinoma (PRCC) is a type of kidney cancer that forms in the lining of the tiny tubes in the kidney that return filtered substances that the body needs back to the blood and remove extra fluid and waste as urine. Most papillary tumors look like long, thin finger-like growths under a microscope. It is also called papillary kidney cancer or PRCC. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the tumor and may interfere with the ability of tumor cells to grow and spread. Cabozantinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals tumor cells to multiply and may also prevent the growth of new blood vessels that tumors need to grow. By these actions it may help slow or stop the spread of tumor cells. Combination therapy with atezolizumab and cabozantinib may shrink the tumor and allow a longer survival time in patients with metastatic renal cell carcinoma.
Recruiting1 award Phase 230 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Lisa Bailey
Clinical Trial Related6 years of experience running clinical trials · Led 53 trials as a Principal Investigator · 18 Active Clinical TrialsTreatments Lisa Bailey has experience with
- Biospecimen Collection
- Paclitaxel
- Atezolizumab
- Bevacizumab
- Fluorouracil
- Pembrolizumab
Breakdown of trials Lisa Bailey has run
Breast Cancer
Breast cancer
Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lisa Bailey specialize in?
Lisa Bailey focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are Stage IV.
Is Lisa Bailey currently recruiting for clinical trials?
Yes, Lisa Bailey is currently recruiting for 18 clinical trials in Martinez California. If you're interested in participating, you should apply.
Are there any treatments that Lisa Bailey has studied deeply?
Yes, Lisa Bailey has studied treatments such as Biospecimen Collection, Paclitaxel, Atezolizumab.
What is the best way to schedule an appointment with Lisa Bailey?
Apply for one of the trials that Lisa Bailey is conducting.
What is the office address of Lisa Bailey?
The office of Lisa Bailey is located at: Contra Costa Regional Medical Center, Martinez, California 94553-3156 United States. This is the address for their practice at the Contra Costa Regional Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.